EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology

Alena Opattova, Katie Jean Znidericz, Giulia Chiabotto, Kristi Buzo, Sabrina Arena

Cancer Treatment Reviews · 2026-11 · 150 · 103202

DOI: 10.1016/j.ctrv.2026.103202 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Alena Opattova und 4 weiteren Autor:innen. Beteiligte Einrichtung: INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo (TO), Italy. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Precision Medicine, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, AIRC Foundation for Cancer Research, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsPrecision MedicineAntineoplastic AgentsModels, BiologicalHumansTumor MicroenvironmentAnimalsCell Culture Techniques, Three Dimensional

Stichwörter der Autor:innen

3D modelschemotherapydrug resistancehigh-throughput drug screeningmicrofluidicsorganoidsspheroids

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo (TO), Italy.
  • INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
  • INOC - Istituto Nazionale Oncologico Candiolo; IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy. Electronic address: sabrina.arena@unito.it.

Förderung

  • NextGenerationEU
  • AIRC Foundation for Cancer Research
  • Ministry of Health
  • Ministero dell'Istruzione dell'Università e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Umberto Veronesi

Zitieren

APA

Opattova, A., Znidericz, K. J., Chiabotto, G., Buzo, K., & Arena, S. (2026). From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology. Cancer Treatment Reviews, 150, 103202. https://doi.org/10.1016/j.ctrv.2026.103202

Vancouver

Opattova A, Znidericz KJ, Chiabotto G, Buzo K, Arena S. From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology. Cancer Treatment Reviews. 2026;150:103202. doi:10.1016/j.ctrv.2026.103202

BibTeX
@article{Opattova2026,
  author = {Opattova, Alena and Znidericz, Katie Jean and Chiabotto, Giulia and Buzo, Kristi and Arena, Sabrina},
  title = {From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {150},
  pages = {103202},
  doi = {10.1016/j.ctrv.2026.103202}
}
Kostenlos starten →